Background: Poor cardiorespiratory fitness (CRF) is an independent predictor of cardiovascular and all-cause mortality. Yet, our knowledge about the prevalence of poor CRF is limited. We investigated the prevalence of poor CRF among middle-aged Danish adults from a community-based health promotion program, including identification of a subgroup with high cardiovascular mortality risk. Methods: This cross-sectional study included 2,253 middle-aged adults, who completed a preventive health check including CRF testing. CRF (ml O 2 /min/kg) was assessed using the Astrand-Ryhming cycle ergometer test. High 10-year cardiovascular mortality risk as defined in the Danish 2016 guidelines was assessed using questionnaires, health examinations, and prescription data from the Danish National Prescription Registry. Results: The prevalence of poor CRF was 51.7% (95% confidence interval [CI] 48.7-54.7) among men and 31.3% (95% CI 28.7-34.1) among women. A total of 216 (19.4%) men and 220 (19.3%) women were identified with a high 10-year cardiovascular mortality risk. Among these, 65.0% of men (95% CI 58.2-71.3) and 44.1% of women (95% CI 37.4-50.9) had poor CRF. Conclusion: Half of men and one third of women participating in a community-based health promotion program were identified with poor CRF. Among high-risk individuals, two thirds of men and almost every second woman had a poor CRF. Our results emphasise the need for effective public health strategies and interventions to increase CRF in the general population and among high-risk individuals in particular in order to improve public health and reduce mortality. 
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Introduction

P
oor cardiorespiratory fitness (CRF) is an independent predictor of all-cause and cardiovascular mortality. 1 Evidence suggests that poor CRF is a stronger predictor of mortality than traditional risk factors such as hypertension, diabetes, smoking, obesity and physical inactivity. [2] [3] [4] Poor CRF is typically defined as the lowest quartile or quintile of the CRF distribution. 5 Compared to the highest CRF level, poor CRF has been associated with a 2-to 5-fold increase in mortality from cardiovascular disease (CVD) and all-causes. 5 Several factors determine CRF, including age, gender, genetics, physical activity, smoking, obesity and morbidity. 6 Physical activity is the primary modifiable CRF determinant. 7 Hence, CRF can be improved through increased physical activity, albeit responsiveness to physical activity is subject to inter-individual variation. 8 Importantly, even modest CRF improvements reduce CVD and all-cause mortality. 7 Thus, it has been suggested that CRF should be incorporated as a vital sign in CVD risk factor evaluation and management. 8 In the European Society of Cardiology (ESC) guidelines on CVD prevention, physical inactivity is classified as a 'qualifier'. 9 This implies that physically inactive individuals may have a higher 10-year risk of a first fatal CVD event than indicated by the Systematic Coronary Risk Evaluation (SCORE) risk chart. As noted, poor CRF is more strongly associated with mortality than physical inactivity. 4, 7 Furthermore, recent evidence imply that poor CRF is associated with particularly high mortality among individuals already identified with a high 10-year risk of fatal CVD. 7, 10, 11 CRF assessment is not routinely used in CVD risk assessment in general practice or in other health care settings. Our knowledge about the prevalence of poor CRF in the general population is limited, and the proportion of poor CRF among individuals already identified with a high 10-year risk of fatal CVD is unknown. Therefore, we investigated the prevalence of poor CRF among middle-aged adults participating in a large Danish community-based health promotion program, including in a subgroup identified with a high 10-year risk of fatal CVD.
Methods
Participants and settings
This cross-sectional study was based on data from The Check Your Health Prevention Program (CHPP), a community-based health promotion program initiated in the municipality of Randers, Denmark, in 2012. 12 The municipality of Randers inhabits approximately 100 000 citizens and is characterised by a less favourable health and socioeconomic profile compared to the national level. 13, 14 The CHPP offers preventive health checks conducted at Randers Health Centre to all 30-49 year-old citizens as of 1 January 2012 (n = 26 216). 12 For the present study, 10 401 randomly selected citizens invited to the CHPP were eligible if they had received a preventive health check with CRF testing between 31 January 2013 and 5 January 2016 and had consented for data to be used scientifically in agreement with the Danish Health Law. Approval by The Danish Data Protection Agency was obtained before study initiation (2013-41-2512).
Measures
Cardiorespiratory fitness CRF (ml O 2 /min/kg) was assessed using a modified version of the Astrand-Ryhming cycle ergometer single-stage test (Monark 939 E Pendulum Ergometer, Monark Exercise AB, Sweden). 15 We employed an initial workload of 75 watt (women) and 100 watt (men), a pedalling frequency of 60-70 rounds/minute, and continuous heart rate (HR) monitoring (Polar T31 heart rate transmitter, Polar, Denmark). HR was recorded at 5½ minutes if a steady-state HR within a target interval (120-170 beats/minute) was reached. If the target interval was not reached within 2 minutes of cycling, the workload was increased by 25 (women) or 50 (men) watt. The test was terminated after 6 minutes or, in case of workload increase, after reaching steady-state and recording the HR. For safety reasons and to avoid unreliable HR responses participants were excluded from CRF testing in case of pacemaker, self-reported beta-blocker use, severe hypertension [blood pressure above 180 (systolic) or 110 (diastolic) mmHg]. 16 CRF level was estimated from the recorded HR and workload as standardised according to age and sex (Monark 939 E Analysis Software, Version 3.0.9, Monark Exercise AB, Sweden) and categorised into poor, fair, average, good or high based on the bench-mark Astrand cut-off levels. 15 
CVD risk measures
Smoking status was assessed by a questionnaire and dichotomised into smokers (i.e. daily, weekly, or occasional smoking) and nonsmokers (i.e. ex-and never-smokers). Body weight and height were measured without shoes to the nearest kg and mm. Waist circumference was measured in cm midway between the lower rib margin and the iliac crest on bare skin after a normal exhalation. Blood pressure (Omron M6 Blood pressure monitor, Omron Healthcare Europe B.V) was measured three times, 1 minute apart, on the left arm after 5 minutes of rest in sitting position and the average blood pressure was used. Lipid profile (total cholesterol and low-density lipoprotein [LDL] ) and HbA 1c were analysed on location using Alere Cholestech LDX System, Alere Denmark, and DCA Vantage Analyzer, Siemens Healthcare, Siemens AG, Germany, respectively.
High-risk definition
In accordance with the Danish 2016 guidelines on CVD prevention, 17 we defined the criteria for high 10-year risk of fatal CVD as one of the following: 1) having established CVD, diabetes, hypertension, or hyperlipidaemia defined as being prescribed antiplatelet (Anatomical Therapeutic Chemical (ATC) group B01AC), glucoselowering (ATC group A10), blood pressure-lowering (ATC group C02/3/7/8/9), or lipid-lowering drugs (ATC group C10), 2) having diabetes measured by HbA 1c !48 mmol/mol, 3) having markedly elevated single risk factors (i.e. blood pressure >160 [systolic] and/ or 100 [diastolic] mmHg, total cholesterol level >8 mM and LDL level >6 mM), or 4) having a SCORE risk (extrapolated to age 60 years) ! 5% of the absolute risk in 10 years for a first fatal CVD event for participants not meeting criteria 1-3. The SCORE risk was assessed based on age (extrapolated to age 60 years as recommended for younger adults in the ESC 2003 guidelines 18 ), gender, total cholesterol, systolic blood pressure and smoking status using the SCORE low risk chart calibrated to the CVD mortality risk in 10 years in the Danish population. 17 Although most CVD events in this younger age group are non-fatal, the SCORE model is the recommended risk assessment tool in Denmark. 17 Prescription information was acquired from the Danish National Prescription Registry, 19 and for each participant, the information was obtained from the year before receiving the health check.
Sociodemographic parameters
Origin, cohabitation status and educational level were retrieved from Statistics Denmark. Origin was dichotomised into Danish (i.e. born in Denmark with a parent being a Danish citizen born in Denmark) and immigrant (i.e. born abroad with no parent being a Danish citizen born in Denmark)/descendant (i.e. born in Denmark with no parent being a Danish citizen born in Denmark). Cohabitation status was dichotomised into cohabitant (i.e. married or cohabiting) and living alone. Educational level was categorised by education length into three levels (=10, >10 to 15 and >15 years).
Statistical methods
The STATA 14.0 software package (Stata Corp LP, TX, USA) was used to analyse frequencies and to describe data. The five CRF groups were dichotomised into "poor CRF" (<34, <30 and <25 ml O 2 /min/kg in men, and <27, <25 and <21 ml O 2 /min/kg in women aged 30-39, 40-49 and 50-54 years, respectively) and "fair-to-high CRF" (!34, !30 and !25 ml O 2 /min/kg in men, and !27, !25 and !21 ml O 2 /min/kg in women aged 30-39, 40-49 and 50-54 years, respectively). 15 Descriptive data are presented as median (interquartile range) for continuous data and as absolute numbers (percentages) for categorical variables. Absolute numbers below 6 are hidden in the tables in accordance with the data protection rules from Statistics Denmark, from which data can be accessed with permission. Characteristics between CRF groups and between included and excluded participants were analysed using independent samples t-test and the chi-squared test. Furthermore, we performed a sensitivity analysis of the prevalence of poor CRF among individuals with a high 10-year CVD mortality risk by excluding individuals identified by drugs that may have been prescribed for other common, not CVD-related conditions (e.g. beta-blockers for migraine prevention). All analyses were stratified according to gender with a statistical significance level of 5%.
Results
Study population
Of the 10 401 citizens invited for the CHPP, 5,124 attended a health check and 2,690 meet all the eligibility criteria for the present study ( figure 1 ). Of the eligible participants, 437 (16,2%) were excluded due to missing or invalid CRF test results or missing information needed to classify 10-year CVD mortality risk yielding a final study population of 2,253 participants. Characteristics of the study population are presented in table 1. Mean and median CRF levels according to gender and age groups are shown in table 2. Generally, men had higher CRF levels than women, and CRF decreased with age in both genders (table 2) .
Poor CRF
The prevalence of poor CRF was 51.7% (95% confidence interval [CI] 48.7-54.7) among men and 31.3% (95% CI 28.7-34.1) among women (table 1) . Men with poor CRF were younger, more often immigrants/descendants, single, lower educated, prescribed glucose-, blood pressure-, and lipid-lowering drugs, and had a poorer cardiometabolic profile, except for LDL, compared to men with fair-to-high CRF (table 1) . Similarly, women with poor CRF had a less favourable cardiometabolic profile and were more often prescribed glucose-, blood pressure-and lipid-lowering drugs. Among sociodemographic parameters, only educational level was lower among women with poor CRF.
Poor CRF among high-risk individuals
A total of 217 (19.5%) men and 220 (19.3%) women were identified with a high 10-year risk of fatal CVD, whereof only 11 men and no women were identified by the SCORE risk (criterion 4). Among these high-risk individuals, 65.0% (95% CI 58.2-71.3) of men and 44.1% (95% CI 37.4-50.9) of women had poor CRF (table 3) . Highrisk men with poor CRF were more often immigrants/descendants, had a lower educational level and a higher body mass index, waist circumference, diastolic blood pressure, total cholesterol and HbA 1c than high-risk men with fair-to-high CRF (table 3) . Among high-risk women, those with poor CRF were characterised by a higher body mass index, waist circumference, diastolic blood pressure and HbA 1c . A sensitivity analysis excluding drugs also used for other common conditions not related to CVD did not change our results.
Excluded vs. included participants
A post hoc analysis of the excluded group (n = 437) revealed that the proportions of immigrants/descendants, singles, lower educated and smokers were higher among excluded participants compared with those included. Furthermore, excluded men were more often prescribed antiplatelet and blood pressure-lowering drugs, and among those not prescribed medications, more were identified with systolic blood pressure above 160 mmHg. Excluded women were more often prescribed glucose-and lipid-lowering drugs, and among those not prescribed medications more had HbA 1c !48 mmol/mol.
Discussion
In this study, we found that among middle-aged Danish adults participating in a community-based health promotion program every second man and every third woman had a poor CRF. Looking specifically at individuals with a high 10-year CVD mortality risk, two thirds of men and almost half of woman had a poor CRF.
A Danish community-based health promotion study from 1991 including 905 individuals (49% men) aged 30-49 years showed that 30% had a poor CRF (lowest Astrand category). 20 Although adverse CVD risk factors were observed in 75% of this population, participants were leaner compared with our study population. Body weight is an important determinant of CRF levels when expressed in relative measures (ml O 2 /min/kg) as opposed to absolute measures (ml O 2 /min). Higher body weight may therefore have contributed to the higher prevalence of poor CRF in our study. Ekblom et al. showed a secular trend of increasing body weight leading to poorer CRF levels in Swedish men between 1990 and 2000. They reported CRF levels comparable with ours in male participants, whereas CRF levels in the Swedish women were higher. 21 The prevalence of poor CRF has been investigated in other countries, including the United States 22 and Canada. 23 However, comparing these results with our study is difficult because different cut-off levels were used to define poor CRF. Therefore, we compared mean CRF levels stratified by age with recently published CRF reference data. 5, [23] [24] [25] [26] Consistent with previous studies, we observed higher CRF levels in men than women and an inverse relationship between CRF and age. Generally, CRF levels among men were lower in our study compared with CRF reference data from Denmark and comparable countries, whereas a less uniform trend was seen among women. 5, [23] [24] [25] [26] Of note, the Danish study had a low participation rate and was not considered fully representative for the entire Danish population. 24 Furthermore, most studies excluded participants with known comorbidity such as hypertension and CVD. Their results thus represent a more healthy study population with a higher expected CRF level than in our study. We found that individuals with poor CRF were more often prescribed CVD-related medication and had a poorer cardiometabolic and sociodemographic profile compared with those with fair-to-high CRF, especially among men. This is in accord with previous studies showing an association between low socioeconomic status and poor CRF. 27, 28 The prevalence of poor CRF in our study was 20% point higher among men compared with women in the high-risk subgroup as well as in the total study population. This may partly be explained by the higher proportion of women with a high educational level compared with men in our study. CVD is more frequent among men than women. 29 Yet, the percentages of high-risk individuals in our study were similar for men and women. High-risk individuals with poor CRF had a poorer cardiometabolic profile as indicated by higher body mass index, waist circumference, diastolic blood pressure, HbA 1c levels and total cholesterol levels compared with high-risk individuals with fair-to-high CRF. Furthermore, unfit high-risk men had a less favourable sociodemographic profile. Several previous studies have investigated the prevalence of high CVD mortality risk in the general population, 30, 31 but our study is the first to specifically investigate the prevalence of poor CRF among individuals with a high CVD mortality risk. Given the use of different guidelines and thresholds for CVD risk factors in previous studies, performing meaningful comparisons with the proportion of high-risk individuals in our study is difficult. Furthermore, none of these studies reported CRF measures. Possible mechanisms explaining the cardioprotective effect of improving CRF include improved cardiometabolic profile, reduced inflammation and enhanced endothelial and cardiac function. 32 Furthermore, recent evidence indicate that improving CRF already in early adulthood may play a critical role in promoting cardiovascular health and interrupting early CVD pathogenesis. 33 Importantly, the benefits of increasing CRF extend beyond those related to CVD, as CRF and regular physical activity have been associated with numerous health benefits, including reduced risk of cancer (colon, breast) and improved musculoskeletal, functional and mental health. 16 The strengths of our study include the use of a population-based cohort of individuals, including individuals with cardiovascular disease, with objectively measured CVD risk factors, data on sociodemographic parameters and complete prescription information ascertained from nationwide registries. All objective measurements were standardised using a written protocol, to which adherence was checked continuously to ensure high data quality. Moreover, the use of a submaximal cycle ergometer test ensured that most participants were able to complete the test regardless of health status.
Important limitations should also be considered. First, the Astrand-Ryhming test predicts the maximal oxygen uptake with a relatively wide margin of error (standard error AE 15%). 34 Second, the predicted maximal oxygen uptake may be slightly lower when employing a submaximal test based on cycling instead of running. 35 Therefore, we cannot exclude that some participants may have been erroneously classified as having poor or high CRF. Underestimation of CRF would lead to overestimation of the prevalence of poor CRF. Third, we excluded 16.2% of otherwise eligible participants due to missing or invalid CRF test data or missing information on CVD risk. According to the post hoc analysis of excluded participants, this may have introduced some degree of selection bias causing an underestimation of the prevalence of poor CRF. Fourth, we used prescription information as a proxy for established CVD, diabetes, hypertension, or hyperlipidaemia. Medical policies may differ between physicians, as physicians are not always aware of or adhere to recommendations. 36 This would lead to an underestimation of the prevalence of high-risk individuals. Furthermore, some of the drugs included may be prescribed for other conditions not related to CVD. However, results were robust in a sensitivity analysis excluding these drugs. Finally, only half of the invited citizens attended a health check in this specific time period of The Check your Health Prevention Program, and attendants were more likely to have a high socioeconomic status compared with non-attenders. As lower socioeconomic status is associated with a lower physical activity level, a lower CRF level, and a poorer CVD risk profile, our results likely underestimate the prevalence of poor CRF in the municipality of Randers as well as in the general population. [37] [38] [39] Overall, our estimates of the prevalence of poor CRF are likely conservative considering the limitations mentioned above. The prevalence of poor CRF may, therefore, be higher in the general CRF, cardiorespiratory fitness; CI, confidence interval; y, years; BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; LDL, low-density lipoprotein. Bold indicates P < 0.05 (poor fitness vs. fair-to-high fitness). population and among high-risk individuals in Denmark. Large cross-national differences in the prevalence of physical inactivity and the use of Danish guidelines to define high CVD risk reduce the generalisability of our results to other countries. 37 We conclude that among middle-aged Danish adults participating in a community-based health promotion program half of men and one third of women had a poor CRF. Among individuals with a high 10-year CVD mortality risk, two thirds of men and almost every second woman had a poor CRF. Individuals with poor CRF had a less favourable sociodemographic and cardiometabolic profile. Our results emphasise the need for effective public health strategies and interventions to increase CRF in the general population and among high-risk individuals in particular. This may positively impact not only cardiovascular health, but also the social inequality in health. 
